Wednesday, May 22, 2013

• Curis to Present at the Deutsche Bank 38th Annual dbAccess Health Care ConferenceGlobeNewswire (Wed, May 22)

Tuesday, May 21, 2013

• American Society Of Clinical Oncology Abstracts Point To Potential Profitsat Seeking Alpha (Tue, May 21)

Friday, May 17, 2013

• CURIS INC FinancialsEDGAR Online Financials (Fri, May 17)

Thursday, May 16, 2013

• Curis Announces Presentation of CUDC-427 and Erivedge(R) Clinical Results at ASCO Annual MeetingGlobeNewswire (Thu, May 16)

Wednesday, May 15, 2013

• 10 ASCO '13 Abstracts You Can Read Right Nowat TheStreet (Wed, May 15)

Monday, May 13, 2013

• Three of WellPoint's directors resign for personal reasonsat Reuters (Mon, May 13)

Friday, May 10, 2013

• Curis Announces Approval of Erivedge(R) in AustraliaGlobeNewswire (Fri, May 10)

Thursday, May 9, 2013

• CURIS INC Files SEC form 10-Q, Quarterly ReportEDGAR Online (Thu, May 9)

Wednesday, May 1, 2013

• Incremental Changes in Regulatory Environment Beneficial to Development-Stage Biotech Companies Due to Emphasis on Closer Working Relationships with the FDA and Drug SponsorsWall Street Transcript (Wed, May 1)

Tuesday, April 30, 2013

• Curis Management Discusses Q1 2013 Results - Earnings Call Transcriptat Seeking Alpha (Tue, Apr 30)
• Curis Earnings: Here’s Why Investors Don’t Like These Resultsat Wall St. Cheat Sheet (Tue, Apr 30)
• CURIS INC Files SEC form 8-K, Results of Operations and Financial Condition, Change in Directors or Principal OfficerEDGAR Online (Tue, Apr 30)
• Q1 2013 Curis, Inc. Earnings Release - Before Market OpenCCBN (Tue, Apr 30)
• Curis Reports First Quarter 2013 Financial ResultsGlobeNewswire (Tue, Apr 30)

Monday, April 29, 2013

• Positive News for RocheZacks (Mon, Apr 29)

Friday, April 26, 2013

• Curis Announces Erivedge(R) Receives Positive CHMP Opinion for Conditional Approval in European UnionGlobeNewswire (Fri, Apr 26)
• UPDATE 1-EU body backs new Roche, Astellas, Sanofi, Vivus drugsat Reuters (Fri, Apr 26)
• Roche’s Skin-Cancer Drug Erivedge Wins EU Agency Backingat Bloomberg (Fri, Apr 26)
• EU agency backs new Roche, Astellas, Sanofi, Vivus drugsat Reuters (Fri, Apr 26)

Thursday, April 25, 2013

• 3 Under-$10 Stocks Making Big Movesat TheStreet (Thu, Apr 25)

Add CRIS News to My Yahoo!